CHC – The Cancer & Hematology Centers

Multiple Myeloma


What kind of cancer is this for: Multiple Myeloma

Phase: III

Who is this trial for? Men and women who have just found out that they have multiple myeloma

What biomarkers are involved? None

What is National Clinical Trial#? NCT03729804

Brief summary of trial: This trial is looking at which treatment plan works better at 12 and 24 months after starting.

Need to know: Both transplant and non-transplant candidates are eligible. Transplant candidates must agree at the time of consent to defer transplant to the end of study treatment.

Where is this trial available? The Cancer & Hematology Centers

For more information, please call 616-975-3065 or email [email protected]